Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Tia Bush Biography and Net Worth

Insider of Centessa Pharmaceuticals

Tia Bush serves as Chief Quality Officer for Centessa Pharmaceuticals. Tia is a global leader who brings nearly thirty years of biotechnology quality experience to the company.

Tia’s extensive career has been spent in quality related roles of increasing responsibility at Amgen, Inc., where she joined in 1993. Most recently, Tia was Chief Quality Officer and Senior Vice President, Global Quality/Environment, Health, Safety and Sustainability where she was responsible for developing, maintaining, and continuously improving the quality management and EHSS management systems. She led an organization of more than 1,400 quality and safety professionals.

Tia currently sits on the Board of Directors for PDA and USC Health Services. She holds a BA in Biological Sciences with a minor in Chemistry from the University of Southern California, Los Angeles, USA.

What is Tia L. Bush's net worth?: The estimated net worth of Tia L. Bush is at least $1.66 million as of May 24th, 2023. Ms. Bush owns 157,102 shares of Centessa Pharmaceuticals stock worth more than $1,660,568 as of April 20th. This net worth evaluation does not reflect any other investments that Ms. Bush may own. Learn More about Tia L. Bush's net worth.
How old is Tia L. Bush?: Ms. Bush is currently 53 years old. There are 5 older executives and no younger executives at Centessa Pharmaceuticals. The oldest executive at Centessa Pharmaceuticals is Dr. Antoine Yver M.D., M.Sc., Executive VP & Chairman of Development, who is 66 years old. Learn More on Tia L. Bush's age.
How do I contact Tia L. Bush?: The corporate mailing address for Ms. Bush and other Centessa Pharmaceuticals executives is THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS, BABRAHAM CAMBRIDGE X0, CB22 3FH. Centessa Pharmaceuticals can also be reached via phone at 44-73-9178-9784 and via email at [email protected]. Learn More on Tia L. Bush's contact information.
Has Tia L. Bush been buying or selling shares of Centessa Pharmaceuticals?: Tia L. Bush has not been actively trading shares of Centessa Pharmaceuticals in the last ninety days. Most recently, Tia L. Bush sold 8,000 shares of the business's stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $4.48, for a transaction totalling $35,840.00. Following the completion of the sale, the insider now directly owns 157,102 shares of the company's stock, valued at $703,816.96. Learn More on Tia L. Bush's trading history.
Who are Centessa Pharmaceuticals' active insiders?: Centessa Pharmaceuticals' insider roster includes Tia Bush (Insider), Francesco De Rubertis (Director), (Bermuda) Gap (Major Shareholder), David Grainger (Insider), Aaron Kantoff (Director), and Saurabh Saha (CEO). Learn More on Centessa Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Centessa Pharmaceuticals?: In the last year, insiders at the sold shares 6 times. They sold a total of 114,211 shares worth more than $972,938.86. The most recent insider tranaction occured on March, 25th when insider Karen M Anderson sold 51,160 shares worth more than $607,780.80. Insiders at Centessa Pharmaceuticals own 11.5% of the company. Learn More about insider trades at Centessa Pharmaceuticals.
Information on this page was last updated on 3/25/2024.

Tia L. Bush Insider Trading History at Centessa Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/24/2023	Sell	8,000	$4.48	$35,840.00	157,102
11/16/2021	Buy	5,000	$12.46	$62,300.00

Tia L. Bush Buying and Selling Activity at Centessa Pharmaceuticals

Centessa Pharmaceuticals Company Overview

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its pipeline products include SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of NT1 with potential expansion into other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; ZF874 in alpha-1 antitrypsin deficiency, a dual-STAT3/5 degrader program in acute myeloid leukemia (AML); MGX292, a protein-engineered variant of human bone morphogenetic protein 9 (BMP9) for the treatment of pulmonary arterial hypertension (PAH); and OX2R Agonists compounds are currently in development for the treatment of narcolepsy, including TAK-861. In addition, its products pipeline comprises CBS001, a neutralizing therapeutic mAb to the inflammatory membrane form of LIGHT for inflammatory / fibrotic diseases; and CBS004, a therapeutic mAb targeting BDCA-2 for the potential treatment of autoimmune diseases, as well as earlier-stage preclinical assets, including ORX750, an orally administered, selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and discovery-stage programs in certain other disease areas. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham, the United Kingdom.

Today's Range

Now: $10.57

$10.26

$10.66

50 Day Range

MA: $10.94

$9.50

$12.20

2 Week Range

Now: $10.57

$3.96

$12.45

Volume

150,106 shs

Average Volume

353,975 shs

Market Capitalization

$1.06 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

Tia Bush Biography and Net Worth

What is Tia L. Bush's net worth?

How old is Tia L. Bush?

How do I contact Tia L. Bush?

Has Tia L. Bush been buying or selling shares of Centessa Pharmaceuticals?

Who are Centessa Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Centessa Pharmaceuticals?